At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you
We recently received an Advantage Proof of Concept Fund award through AWM which allowed us to get an idea to market. These types of funds are valuable to small businesses wanting to develop new ideas and realise commercial value.
